The artificial
pancreas — a device which monitors blood glucose in patients with type 1 diabetes and then
automatically adjusts levels of insulin entering the body — is likely to be available
by 2018, conclude authors of a paper in Diabetologia (the journal of the European Association for the Study of Diabetes).